ZENTALIS PHARMACEUTICALS INC (ZNTL) Institutional Ownership Changes & 13F Activity

ZENTALIS PHARMACEUTICALS INC (ZNTL). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Orbimed Advisors Llc, D. E. Shaw & Co., Inc., Millennium Management Llc, Citadel Advisors Llc, and Adar1 Capital Management, Llc.

InstitutionTypeChange in sharesChange Position %SharesReported stock balancePortfolio quarterFiling date
Manufacturers Life Insurance Company, TheBuy+14,28914,289$69.30KQ2 2026Sep 09, 2026
Citadel Advisors LlcBuy+566,320+32.7%2,298,403$11.15MQ2 2026Sep 02, 2026
California State Teachers Retirement SystemBuy+689689$3.34KQ2 2026Aug 24, 2026
Seven Fleet Capital Management LpBuy+207,600+188.7%317,600$1.45MQ2 2026Aug 17, 2026
Stonepine Capital Management, LlcSell-107,517-40.0%161,583$783.68KQ2 2026Aug 17, 2026
Orbimed Advisors LlcBuy+1,390,5761,390,576$6.74MQ2 2026Aug 14, 2026
D. E. Shaw & Co., Inc.Sell-937,532-63.2%546,566$2.65MQ2 2026Aug 14, 2026
Millennium Management LlcSell-625,541-48.5%664,281$3.22MQ2 2026Aug 14, 2026
Adar1 Capital Management, LlcBuy+508,114+351.3%652,750$3.17MQ2 2026Aug 14, 2026
Jane Street Group, LlcSell-475,944-97.1%14,395$69.82KQ2 2026Aug 14, 2026
Barclays PlcSell-432,361-73.1%158,856$770.45KQ2 2026Aug 14, 2026
Susquehanna International Group, LlpSell-356,144-62.3%215,113$1.04MQ2 2026Aug 14, 2026
Ishara Investments LpSell-205,000-16.7%1,025,000$4.97MQ2 2026Aug 14, 2026
Invesco Ltd.Buy+161,657161,657$784.04KQ2 2026Aug 14, 2026
Charles Schwab Investment Management IncBuy+120,824+236.5%171,911$833.77KQ2 2026Aug 14, 2026
Susquehanna Portfolio Strategies, LlcBuy+112,122112,122$543.79KQ2 2026Aug 14, 2026
Cdc Financial, Inc.Sell-106,000-37.4%177,762$862.15KQ2 2026Aug 14, 2026
Goldman Sachs Group IncSell-90,114-19.5%372,564$1.81MQ2 2026Aug 14, 2026
Exoduspoint Capital Management, LpBuy+74,96674,966$363.58KQ2 2026Aug 14, 2026
Graham Capital Management, L.P.Sell-70,069-75.8%22,358$108.44KQ2 2026Aug 14, 2026
Squadron Capital Management LlcBuy+69,000+1.9%3,700,000$17.95MQ2 2026Aug 14, 2026
Two Sigma Investments, LpBuy+68,410+2.3%3,024,936$14.67MQ2 2026Aug 14, 2026
Sei Investments CoBuy+64,528+33.7%256,079$1.24MQ2 2026Aug 14, 2026
Qube Research & Technologies LtdSell-62,310-9.8%574,806$2.79MQ2 2026Aug 14, 2026
Wells Fargo & Company/MnBuy+41,897+4189700.0%41,898$203.20KQ2 2026Aug 14, 2026
Price T Rowe Associates IncBuy+41,04941,049$200.00KQ2 2026Aug 14, 2026
Verdad Advisers, LpBuy+39,60839,608$192.10KQ2 2026Aug 14, 2026
Xtx Topco LtdSell-32,814-10.2%289,693$1.41MQ2 2026Aug 14, 2026
Metlife Investment Management, LlcBuy+30,09530,095$145.96KQ2 2026Aug 14, 2026
Susquehanna Fundamental Investments, LlcBuy+25,96225,962$125.92KQ2 2026Aug 14, 2026
Showing 30 of 117

Frequently asked questions about ZNTL activity

  • Which institutional owners are buying ZNTL?

    Institutional owners buying ZNTL include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in ZNTL activity?

    "Buy" means an investor increased their reported position in ZNTL compared to the prior reporting period. This reflects growing exposure to ZENTALIS PHARMACEUTICALS INC (ZNTL) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in ZNTL increasing?

    Institutional interest in ZNTL can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.